Agios Pharmaceuticals, Inc. (AGIO)
34.92
+0.47
(+1.36%)
USD |
NASDAQ |
Apr 16, 16:00
34.60
-0.32
(-0.92%)
After-Hours: 20:00
Agios Pharmaceuticals Free Cash Flow : -377.29M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 5.964B |
| Biogen, Inc. | 1.969B |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Apellis Pharmaceuticals, Inc. | 45.01M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -96.21M |
| Cash from Investing (Quarterly) | 90.08M |
| Cash from Financing (Quarterly) | 2.557M |
| Free Cash Flow Per Share (Quarterly) | -1.669 |
| Free Cash Flow to Equity (Quarterly) | -93.02M |
| Free Cash Flow to Firm (Quarterly) | -97.33M |
| Free Cash Flow Yield | -18.64% |